belumosudil mesilate · Medicine question

What is the elimination half-life of belumosudil mesilate in patients with chronic graft-versus-host disease?

Name: What is the elimination half-life of belumosudil mesilate in patients with chronic graft-versus-host disease?
Published: 2026-11-08T13:39:38.964Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Population pharmacokinetic modelling in patients with chronic graft-versus-host disease showed an elimination half-life for belumosudil mesilate of 19.0 hours, with a coefficient of variation of 39%.

Sources for this answer

REZUROCK 200 mg film-coated tablets.SANOFI · emc · SmPC §5.2 Pharmacokinetic properties · Version 8Document updated 3 September 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about belumosudil mesilate